These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35135946)

  • 1. [Successful outcome of allogeneic hematopoietic stem cell transplantation for systemic mastocytosis complicated with acute myeloid leukemia].
    Maegaki M; Kawamura K; Hara K; Suzuki S; Hosoda Y; Kuwamoto S; Motokura T; Fukuda T
    Rinsho Ketsueki; 2022; 63(1):14-19. PubMed ID: 35135946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
    Ustun C; Corless CL; Savage N; Fiskus W; Manaloor E; Heinrich MC; Lewis G; Ramalingam P; Kepten I; Jillella A; Bhalla K
    Leuk Res; 2009 May; 33(5):735-41. PubMed ID: 18986703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of systemic mastocytosis with RUNX1-RUNX1T1 positive acute myeloid leukemia treated with sequential avapritinib after allogeneic hematopoietic stem cell transplantation and literature review].
    Wang J; Zu YL; Gui RR; Li Z; Zhang Y; Zhou J
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):505-508. PubMed ID: 38964927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute myeloid leukemia evolving from KIT D816-mutated systemic mastocytosis relapsing two months after completion of chemotherapy].
    Harao T; Yamada A; Kinoshita M; Sawa D; Saito Y; Kamimura S; Miyachi H; Ogino T; Kodama Y; Okamoto Y; Kawano Y; Moritake H
    Rinsho Ketsueki; 2019; 60(5):378-381. PubMed ID: 31167998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Remission of Acute Myeloid Leukemia Developed From Systemic Mastocytosis by Conventional Chemotherapy.
    Yamada A; Kinoshita M; Sawa D; Saito Y; Kamimura S; Miyachi H; Moritake H
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):e402-e404. PubMed ID: 30044348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of systemic mastocytosis associated with acute myeloid leukemia terminating as aleukemic mast cell leukemia after allogeneic hematopoietic stem cell transplantation.
    Bae MH; Kim HK; Park CJ; Seo EJ; Park SH; Cho YU; Jang S; Chi HS; Lee KH
    Ann Lab Med; 2013 Mar; 33(2):125-9. PubMed ID: 23483057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-mastocytosis effect after donor lymphocyte infusion: Proof of principle.
    Hägglund H; Yavuz AS; Dreimane A; Malm C; Sundin A; Sander B; Nilsson G
    Eur J Haematol; 2021 Feb; 106(2):290-293. PubMed ID: 33010068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia.
    Mahadeo KM; Wolgast L; McMahon C; Cole PD
    Pediatr Blood Cancer; 2011 Oct; 57(4):684-7. PubMed ID: 21671435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
    Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
    Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.
    Fritsche-Polanz R; Fritz M; Huber A; Sotlar K; Sperr WR; Mannhalter C; Födinger M; Valent P
    Mol Oncol; 2010 Aug; 4(4):335-46. PubMed ID: 20471335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis.
    Escribano L; Garca-Montero A; Núñez-López R; López-Jiménez J; Almeida J; Prados A; Orfao A
    J Allergy Clin Immunol; 2004 Jul; 114(1):28-33. PubMed ID: 15241340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia.
    Pourhassan H; Kim Y; Pullarkat V
    Eur J Haematol; 2023 Feb; 110(2):213-216. PubMed ID: 36335580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.
    Klusmann JH; Reinhardt D; Zimmermann M; Kremens B; Vormoor J; Dworzak M; Creutzig U; Klingebiel T
    Haematologica; 2012 Jan; 97(1):21-9. PubMed ID: 21933851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation.
    Chen TY; Chen JS; Huang WT; Su WC; Tsao CJ
    Bone Marrow Transplant; 2003 Jul; 32(1):111-4. PubMed ID: 12815487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofarabine does not negatively impact the outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
    Mathisen MS; Kantarjian H; Jabbour E; Garcia-Manero G; Ravandi F; Faderl S; Borthakur G; Cortes JE; Quintás-Cardama A
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):139-43. PubMed ID: 23276886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.
    Hennessy B; Giles F; Cortes J; O'brien S; Ferrajoli A; Ossa G; Garcia-Manero G; Faderl S; Kantarjian H; Verstovsek S
    Am J Hematol; 2004 Nov; 77(3):209-14. PubMed ID: 15495258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
    Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report.
    Cheng J; Liao Y; Bin T; OUYang J; Chen S; Chen X; Zou W
    Curr Med Res Opin; 2020 Nov; 36(11):1807-1812. PubMed ID: 32936052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial.
    Hyakuna N; Hashii Y; Ishida H; Umeda K; Takahashi Y; Nagasawa M; Yabe H; Nakazawa Y; Koh K; Goto H; Fujisaki H; Matsumoto K; Kakuda H; Yano M; Tawa A; Tomizawa D; Taga T; Adachi S; Kato K
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27875. PubMed ID: 31309713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.